Journals / Ankara Medical Journal / 2022 / Cilt: 22 - Sayı: 2

CAN ISCHEMIA MODIFIED ALBUMIN LEVEL BE REGARDED AS AN INDICATIVE MARKER OF ULCERATIVE COLITIS AND ITS ACTIVITY?

Pages
230–238
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: When UC patients were compared to the control group, higher IMA levels were observed in the patient’s serum (0.48±0.25 g/L vs. 0.28±0.08 g/L), and the difference was statistically significant (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: We studied the effectivity of serum ischemia-modified albumin (IMA) levels in the diagnosis and clinical activity of patients suffering from Ulcerative Colitis (UC).
📊
Key Findings & Data:Materials and Methods: Eighty-eight clinically and pathologically confirmed UC patients and 48 age- and sex- matched healthy volunteers were included in the study.
💡
Conclusion & Impact:Results: When UC patients were compared to the control group, higher IMA levels were observed in the patient’s serum (0.48±0.25 g/L vs. 0.28±0.08 g/L), and the difference was statistically significant (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: We studied the effectivity of serum ischemia-modified albumin (IMA) levels in the diagnosis and clinical activity of patients suffering from Ulcerative Colitis (UC). Materials and Methods: Eighty-eight clinically and pathologically confirmed UC patients and 48 age- and sex- matched healthy volunteers were included in the study. The patients were classified according to the Rachmilewitz Score [Endoscopy activity index (EAI)], and those with a score below five were considered in the remission group, and those above five were considered as active disease group. The IMA levels were calculated by the colorimetric method. Results: When UC patients were compared to the control group, higher IMA levels were observed in the patient’s serum (0.48±0.25 g/L vs. 0.28±0.08 g/L), and the difference was statistically significant (p

🔖

Cite This Article

CENGİZ, M., SARI, O., SAHİN, A. (2022). CAN ISCHEMIA MODIFIED ALBUMIN LEVEL BE REGARDED AS AN INDICATIVE MARKER OF ULCERATIVE COLITIS AND ITS ACTIVITY?. Ankara Medical Journal, Cilt: 22 - Sayı: 2, 230–238. https://ajindex.com/articles/441683

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Tate MC. Surgery for gliomas. Cancer Treat Res. 2015;163:31-47
  2. Jackson B, De Cruz P. Algorithms to facilitate shared decision-making for the management of mild-to- moderate ulcerative colitis. Expert Rev Gastroenterol Hepatol. 2018;12(11):1079-100
  3. Vera JC, Rosen OM. Functional expression of mammalian glucose transporters in Xenopus laevis oocytes: evidence for cell-dependent insulin sensitivity. Mol Cell Biol. 1989;9(10):4187-95
  4. Roy D, Quiles J, Gaze DC, Collinson P, Kaski JC, Baxter GF. Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin. Heart. 2006;92(1):113-4
  5. Oh BJ, Seo MH, Kim HS. Insignificant role of the N-terminal cobalt-binding site of albumin in the assessment of acute coronary syndrome: discrepancy between the albumin cobalt-binding assay and N- terminal-targeted immunoassay. Biomarkers. 2012;17(5):394-401
  6. Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ. 1989;298(6666):82- 7. Bar-Or D, Winkler JV, Vanbenthuysen K, Harris L, Lau E, Hetzel FW. Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin I. Am Heart J. 2001;141(6):985-91
  7. Yakut I, Tayman C, Oztekin O, Namuslu M, Karaca F, Kosus A. Ischemia-modified albumin may be a novel marker for the diagnosis and follow-up of necrotizing enterocolitis. J Clin Lab Anal. 2014;28(3):170-7
  8. Pavlick KP, Laroux FS, Fuseler J et al. Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease. Free Radic Biol Med. 2002;33(3):311-22
  9. Grisham MB. Oxidants and free radicals in inflammatory bowel disease. Lancet. 1994;344(8926):859- 61
  10. Erdem SS, Yerlikaya FH, Cicekler H, Gul M. Association between ischemia-modified albumin, homocysteine, vitamin B(12) and folic acid in patients with severe sepsis. Clin Chem Lab Med. 2012;50(8):1417-21
  11. Williams J, Bergmann T. Probable inflammatory bowel disease in a child: assessment and conservative management. J Chiropr Med. 2003;2(4):157-62
  12. Zhu H, Li YR. Oxidative stress and redox signaling mechanisms of inflammatory bowel disease: updated experimental and clinical evidence. Exp Biol Med (Maywood). 2012;237(5):474-80
  13. Ellidag HY, Bulbuller N, Eren E et al. Ischemia-modified albumin: could it be a new oxidat